|
|
Blood, 15 February 2007, Vol. 109, No. 4, pp. 1574-1583.
Prepublished online as a Blood First Edition Paper on October 12, 2006; DOI 10.1182/blood-2006-06-032961.
 Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
Contribution of Toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria
Greg Elson1,
Irène Dunn-Siegrist2,3,
Bruno Daubeuf1, and
Jérome Pugin2,3
1 NovImmune SA, Geneva, Switzerland;
2 Division of Intensive Care, University Hospital of Geneva, Switzerland;
3 Department of Microbiology and Molecular Medicine, University of Geneva, Switzerland
Innate recognition of bacteria is a key step in the activation of inflammation and coagulation, and it is dependent on pathogen-associated molecular pattern (PAMP) ligation to Toll-like receptors (TLRs) and CD14. The dominant receptors activated when cells encounter a whole bacterium, which express several PAMPs, are poorly defined. Herein, we have stimulated various human cells with prototypic Gram-negative and Gram-positive bacteria. Receptor-dependent responses to whole bacteria were assessed using both TLR-transfected cells and specific monoclonal antibodies against TLRs, MD-2, and CD14. Enterobacteria-activated leukocytes and endothelial cells in a TLR4/MD-2–dependent manner, most likely via lipopolysaccharide (LPS). TLR2 activation was observed with a high bacterial inoculum, and in epithelial cells expressing TLR2 but not TLR4. Pseudomonas aeruginosa stimulated cells by both TLR2 and TLR4/MD-2. Gram-positive bacteria activated cells only at high concentrations, in a partially TLR2-dependent but TLR4/MD-2–independent manner. Either TLR or CD14 neutralization blocked activation to all bacterial strains tested with the exception of some Gram-positive strains in whole blood in which partial inhibition was noted. This study identifies dominant TLRs involved in responses to whole bacteria. It also validates the concept that host cell activation by bacterial pathogens can be therapeutically reduced by anti-TLR4, -TLR2, and -CD14 mAbs.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
B. M. Buchholz, R. S. Chanthaphavong, and A. J. M. Bauer
Nonhemopoietic Cell TLR4 Signaling Is Critical in Causing Early Lipopolysaccharide-Induced Ileus
J. Immunol.,
November 15, 2009;
183(10):
6744 - 6753.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-H. Park, Y.-G. Kim, and G. Nunez
RICK Promotes Inflammation and Lethality after Gram-Negative Bacterial Infection in Mice Stimulated with Lipopolysaccharide
Infect. Immun.,
April 1, 2009;
77(4):
1569 - 1578.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Szczepanski, M. Czystowska, M. Szajnik, M. Harasymczuk, M. Boyiadzis, A. Kruk-Zagajewska, W. Szyfter, J. Zeromski, and T. L. Whiteside
Triggering of Toll-like Receptor 4 Expressed on Human Head and Neck Squamous Cell Carcinoma Promotes Tumor Development and Protects the Tumor from Immune Attack
Cancer Res.,
April 1, 2009;
69(7):
3105 - 3113.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Roger, C. Froidevaux, D. Le Roy, M. K. Reymond, A.-L. Chanson, D. Mauri, K. Burns, B. M. Riederer, S. Akira, and T. Calandra
Protection from lethal Gram-negative bacterial sepsis by targeting Toll-like receptor 4
PNAS,
February 17, 2009;
106(7):
2348 - 2352.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. H. Kogut and K. Klasing
An immunologist's perspective on nutrition, immunity, and infectious diseases: Introduction and overview
J. Appl. Poult. Res.,
January 1, 2009;
18(1):
103 - 110.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Sandanger, L. Ryan, J. Bohnhorst, A.-C. Iversen, H. Husebye, O. Halaas, L. Landro, P. Aukrust, S. S. Froland, G. Elson, et al.
IL-10 Enhances MD-2 and CD14 Expression in Monocytes and the Proteins Are Increased and Correlated in HIV-Infected Patients
J. Immunol.,
January 1, 2009;
182(1):
588 - 595.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Spiller, G. Elson, R. Ferstl, S. Dreher, T. Mueller, M. Freudenberg, B. Daubeuf, H. Wagner, and C. J. Kirschning
TLR4-induced IFN-{gamma} production increases TLR2 sensitivity and drives Gram-negative sepsis in mice
J. Exp. Med.,
August 4, 2008;
205(8):
1747 - 1754.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Tissieres, I. Dunn-Siegrist, M. Schappi, G. Elson, R. Comte, V. Nobre, and J. Pugin
Soluble MD-2 is an acute-phase protein and an opsonin for Gram-negative bacteria
Blood,
February 15, 2008;
111(4):
2122 - 2131.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. S. Munford
Sensing Gram-Negative Bacterial Lipopolysaccharides: a Human Disease Determinant?
Infect. Immun.,
February 1, 2008;
76(2):
454 - 465.
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Dunn-Siegrist, O. Leger, B. Daubeuf, Y. Poitevin, F. Depis, S. Herren, M. Kosco-Vilbois, Y. Dean, J. Pugin, and G. Elson
Pivotal Involvement of Fc{gamma} Receptor IIA in the Neutralization of Lipopolysaccharide Signaling via a Potent Novel Anti-TLR4 Monoclonal Antibody 15C1
J. Biol. Chem.,
November 30, 2007;
282(48):
34817 - 34827.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Daubeuf, J. Mathison, S. Spiller, S. Hugues, S. Herren, W. Ferlin, M. Kosco-Vilbois, H. Wagner, C. J. Kirschning, R. Ulevitch, et al.
TLR4/MD-2 Monoclonal Antibody Therapy Affords Protection in Experimental Models of Septic Shock
J. Immunol.,
November 1, 2007;
179(9):
6107 - 6114.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Bhatnagar, K. Shinagawa, F. J. Castellino, and J. S. Schorey
Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo
Blood,
November 1, 2007;
110(9):
3234 - 3244.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Tamassia, V. Le Moigne, F. Calzetti, M. Donini, S. Gasperini, T. Ear, A. Cloutier, F. O. Martinez, M. Fabbri, M. Locati, et al.
The MYD88-Independent Pathway Is Not Mobilized in Human Neutrophils Stimulated via TLR4
J. Immunol.,
June 1, 2007;
178(11):
7344 - 7356.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
